China Large Volume Parenteral (LVP) Industry Report, 2013-2015
Published Date » 2013-11-29
No. Of Pages » 65
Under the context of China's medical reform and sustainable development of the pharmaceutical market, the output and demand of Large Volume Parenteral (LVP) which is one of the top five Chinese preparations have grown year by year. In 2006-2012, China’s injection output presented the CAGR of 19.2%. However, due to the low barriers to entry, China has seen some signs of the surplus injection capacity, which exceeds the demand by roughly 40%.
Overcapacity and fierce competition are caused by the irrational injection product structure and homogeneity. For example, the output and sales volume of fluid balance injection products with low added value account for 89% of the injection market, but the sales revenue only shares 47%. At the same time, the market demand for amino acids, fat emulsion dual-chamber bags, fat emulsion, total parenteral nutrition, hydroxyethyl starch and unique traditional Chinese medicine injection is quite strong.
Compared to Europe and other developed countries, the concentration degree of Chinese LVP market is still lower. At present, 200 ones of 400 qualified Chinese LVP enterprises run business soundly. By output, the top 10 Chinese companies contribute about 65%; in terms of sales revenue, they devote about 40 %.
Like other chemical preparation segments, Chinese high-end LVP market is still dominated by foreign pharmaceutical companies such as Japan Otsuka, Germany Fresenius Kabi, and USA Baxter.
Take fat emulsion products for example. Fat emulsion is imported by China frequently as a blood and hematopoietic system drug in recent years, with its import volume having been at the high level of typical urban hospitals in 22 Chinese cities for consecutive years. Particularly, the procurement value of moderate and long-chain fat emulsion imported by Chinese typical hospitals hit RMB354million. In China, fat emulsion injection suppliers include Kelun Pharma, Sino-Swed Pharmaceutical Corp, Ltd. (under Fresenius Kabi) and Guangzhou Baxter Qiaoguang (under Baxter) with the respective output of 14.19 million bottles/bags, 8.1 million bottles / bags (including medium/long-chain fat emulsion) and 5.69 million bottles/bags (medium/long-chain fat emulsion) in 2012.
The report highlights the followings:
- Status quo, competition patterns, product structure, regional distribution and development forecast of Chinese LVP market;
- Status quo and competition patterns of fluid balance injection, therapeutic injection, nutrition injection, injection for blood volume expansion and peritoneal dialysis fluid injection and other market segments;
- Operation, LVP business and prospects of 10 companies including Kelun Pharma, China Resources Double-Crane, Fengyuan Pharmaceutical, Huaren Pharmaceutical, Southwest Pharmaceutical and Lijun International Pharmaceutical.
TABLE OF CONTENT
1 Overview of LVP
1.1 Definition and Classification
1.2 Industry Chain
2 Overview of China LVP Industry Development
2.1 Status Quo
2.2 Competition Pattern
2.3 Product Structure
2.4 Regional Distribution
2. 5 Development Forecast
3 Chinese LVP Market Segments
3.1 Injection for Fluid Balance
3.2 Therapeutic Injection
3.3 Nutritious Injection
3.3.1 Fructose Injection
3.3.2 Amino Acid Injection
3.3.3 Fat Emulsion Injection
3.4 Injection for Blood Volume Expansion
3.4.1 Dextran Injection
3.4.2 Hydroxyethyl Starch Injection
3.5 Peritoneal Dialysis Solution
4 Main Companies
4.1 Kelun Pharma
4.1.3 Revenue Structure
4.1.4 Gross Margin
4.1.5 Clients and Suppliers
4.1.6 R & D and Investment
4.1.7 LVP Business
4.1.8 Development Forecast
4.2 China Resources Double-Crane
4.2.3 Revenue Structure
4.2.4 Gross Margin
4.2.5 Major Clients
4.2.6 LVP Business
4.2.7 Development Forecast
4.3 Fengyuan Pharmaceutical
4.3.3 Revenue Structure
4.3.4 Gross Margin
4.3.5 Clients and Suppliers
4.3.6 LVP Business
4.3.7 Development Forecast
4.4 Huaren Pharmaceutical
4.4.3 Revenue Structure
4.4.4 Gross Margin
4.4.5 Clients and Suppliers
4.4.6 R & D and Investment
4.4.7 Development Forecast
4.5 Southwest Pharmaceutical
4.5.3 Revenue Structure
4.5.4 Gross Margin
4.5.5 Major Clients
4.5.6 LVP Business
4.5.7 Development Forecast
4.6 Lijun International Pharmaceutical (Holding)
4.6.3 Shijiazhuang No.4 Pharmaceutical
4.7 Other Companies
4.7.1 Qingzhou Yaowang Medicine
4.7.2 Jilin Dubang Pharmaceutical
4.7.3 Shandong Lukang Cisen Pharmaceutical
4.7.4 China Otsuka Pharmaceutical
List of TablesNA
List of FiguresNA
Cement Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019
By - Transparency Market Research
Cement is a key building material which is used as a binder. Clay and limestone are key raw materials used in the manufacture of cement. Cement can also be used in mixture as a concrete and mortar. Mortar is formed by mixing cement with sand whereas concrete is formed by mixing cement, sand, fine aggregate and coarse aggregate. Mortar is used to bind blocks, stone and bricks into walls. Concrete is used in varied constructional purposes. One of the major drivers for cement market is steady and consistent growth in construction industry. Strong growth prospects of construction industry...
Wound Closure Devices Market- Global Industry Analysis, Market Size, Share, Trends, Analysis, Growth And Forecasts 2010 - 2017
By - Transparency Market Research
Wound closure devices is a relatively new device category, these devices assist in help bring the edges of the open wound closer together and keep them together once they touch. These devices find their applications in surgical operations for the closure of surgical incisions and also for wounds caused accidently. The different types of wound closure devices are sutures, mechanical wound closure devices, wound strips and skin adhesives. Globally, the wound closure market is dominated by sutures followed by mechanical wound closure devices. The industry is constantly...
Coxsackievirus Diagnostics Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019
By - Transparency Market Research
Coxsackieviruses are non-enveloped viruses belonging to the picornaviridae family and enterovirus genus that possess linear single-stranded RNA as their genetic material. Based on their pathogenecity tested on mice, they are further categorized into group A and group B viruses. Group A viruses are known to cause skin and mucous membrane infections leading to disorders such as herpangina, hand-foot-and-mouth (HFM) disease and acute hemorrhagic conjunctivitis (AHC), whereas, group B viruses infect the pancreas, liver and heart leading to various conditions such as pericarditis,...
We will be happy to help you find what you need.
Please call us or write us:
Please call us or write us:
866-997-4948 (Us-Canada Toll Free)
Select License type:
Alternative Payment Method
- Global and China Fireplace Parts Industry 2014 Market Research Report
- Global and China Other Fireproofing Materials Industry 2014 Market Research Report
- Global and China Fireplace Sets & Accessories Industry 2014 Market Research Report
- Global and China Turbocharger Industry 2014 Market Research Report
- Global and China Cork Flooring Industry 2014 Market Research Report
- Global and China Eleven Ene Amide Sulfo Succinate Sodium Salt Industry 2014 Market Research Report
- Global and China Fireplaces Industry 2014 Market Research Report
- Global and China Bamboo Flooring Industry 2014 Market Research Report
- Global and China Anti-Static Flooring Industry 2014 Market Research Report
- Global and China Decyltrimethylammonium Chloride Industry 2014 Market Research Report
Solar Power Generation Reaches Record High in the U.S. in 2013
Mar 6, 2014
Solar power accounted for an even larger share in the total volume of electricity generated in the United Sates in 2013. According to a latest report published by the Solar Energy Industries Association along with GTM Research suggests that this form of energy is increasingly becoming a part of the main stream U.S. power grid. So, it is not surprising that the production of solar...
Reynolds focus on Lorillard tobacco bid
Mar 5, 2014
U.S. tobacco giant - Reynolds American has stated a bid for its biggest rival Lorillard in the market. This bid has set quakes on the global tobacco market that is already being remodeled by declining smoking rates and growth of electronic cigarettes. Lorillard shares closed at 9.3 percent at $53.61 early Monday, giving a market value of $19.6bn. Reynolds bid could not be fairly...
Ecommerce to be New Growth Driver in Chinese Economy
Mar 4, 2014
Chinese ecommerce companies are set to make it big in the coming years with the market for ecommerce in China likely to grow to a whopping value of USD 8.17 trillion by 2020. This is what the vice-president of Alibaba estimates. China has largely been an export oriented society and it is online retail that is currently enabling the country to make a shift from this status. The...
Protect fruits from QFF flies
Mar 3, 2014
Queensland Fruit fly (QFF) is considered to be one of Australia’s intensely serious insect pests affecting the horticultural industry in the Central Tablelands and beyond. The Central Tablelands Local Land Services are knee-deep into testing a QFF monitoring program associated with the horticulturists in the Orange area. The authorities of this organization are open to...
Australian Companies Post Higher Profits Beating ExpectationsAustralian Companies Post Higher Profits Beating Expectations
Feb 28, 2014
Several large companies in Australia have beaten expectations by posting higher earnings and profits than expected. This is being regarded as one of the most positive reporting sessions since the last couple of years. The reporting session of February wrapped up with over 50% of the listed companies in Australia posting profits or beating expectations of earnings. Though there...